Thomas Cavanagh
Keine laufenden Positionen mehr
Profil
Thomas Cavanagh was the founder of Oxular Ltd., where he held the title of Chief Executive Officer & Director from 2014 to 2023.
Oxular Ltd.
was founded in 2014.
Mr. Cavanagh's former job was as Vice President-Quality & Regulatory Affairs at Symbios Medical Products LLC.
Ehemalige bekannte Positionen von Thomas Cavanagh
| Unternehmen | Position | Ende |
|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Gründer | 11.09.2023 |
Symbios Medical Products LLC
 Symbios Medical Products LLC Electronic Equipment/InstrumentsElectronic Technology Symbios Medical Products LLC designs, manufactures and markets pain management systems. It designs pain management systems commonly known as ambulatory disposable pain pumps as the GOPump, GOPump Dual the GOBlock and GOBlock-SF Continuous Peripheral Nerve Block Pumps are used for the post operative management of acute pain and they deliver non-narcotic pain medication to surgical sites or provide a regional pain block to a specific area of the body below the neck. The company was founded in 2003 and is headquartered in Indianapolis, IN. | General Counsel | 30.08.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Symbios Medical Products LLC
Symbios Medical Products LLC Electronic Equipment/InstrumentsElectronic Technology Symbios Medical Products LLC designs, manufactures and markets pain management systems. It designs pain management systems commonly known as ambulatory disposable pain pumps as the GOPump, GOPump Dual the GOBlock and GOBlock-SF Continuous Peripheral Nerve Block Pumps are used for the post operative management of acute pain and they deliver non-narcotic pain medication to surgical sites or provide a regional pain block to a specific area of the body below the neck. The company was founded in 2003 and is headquartered in Indianapolis, IN. | Electronic Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
